TY - JOUR
T1 - Effect of long chain triglyceride infusion on glucose metabolism in man
AU - Thiébaud, Daniel
AU - DeFronzo, Ralph A.
AU - Jacot, Eric
AU - Golay, Alain
AU - Acheson, Kevin
AU - Maeder, Evelyne
AU - Jéquier, Eric
AU - Felber, Jean Pierre
N1 - Funding Information:
From the Division of Clinical Biochemistry, C.H.U. V., 1011 Lausanne; The Institute of Physiology, University of Lausanne, Switzerland; and the Department of Medicine, Yale University. School of Medicine, New Haven, Connecticut. Receivedfor publication May 26.1982. The work was supported in part by the Swiss National Science Foundation, grant No 3 770 0 80. and by the Raymond Berger Foundation for Diabetic Research in Lausanne. Address reprint requests to Prof. J.-P. Felber. Division de Biochimie Clinique. Dtpartement de Msdecine. C.H.U. V., 101 I LAVSANNE Switzerland. 0 1982 by Grune & Stratton, Inc. 0026-0495/82/311 1-0010601.00/0
PY - 1982/11
Y1 - 1982/11
N2 - The effect of long chain triglyceride infusions (Intralipid 20%, 1 ml/min) on total body glucose uptake, glucose oxidation and glucose storage was examined in 25 healthy young volunteers by employing the euglycemic insulin clamp technique in combination with indirect calorimetry. Insulin was infused at three different rates (0.5, 2 and 4 mU/kg min) to achieve steady state hyperinsulinemic plateaus of 60 ± 4, 170 ± 10 and 420 ± 15 μU/ml. Prior to Intralipid infusion, the mean basal plasma free fatty acid concentration of all subjects was 385 ± 8 μmole/l. Following 90 min Intralipid infusion, the mean plasma free fatty acid level was increased to 760 ± 20 μmole/l (p < 0.001). At each insulin dose level, hyperlipidemia caused a significant reduction in total glucose uptake (5.9-3.5, 9.9-7.1, 11.1-8.8 mg/kg min, all p < 0.001. The decrease in total body glucose uptake was reflected by a decrease in both total glucose oxidation (2.4-1.6, 3.4-2.2, 3.7-2.8 mg/kg min, all p < 0.001) and glucose storage (3.6-1.9, 6.5-4.9, 7.4-5.9 mg/kg min, all p < 0.001). Basal glucose oxidation (1.3 ± 0.1 mg/kg min) fell by about 30% following 90 min of Intralipid infusion (0.9 ± 0.1 mg/kg min). Six additional subjects were studied with a lower infusion rate of Intralipid (0.5 ml/min). In these studies, insulin was infused at two different doses (0.5 and 2 mU/kg min) to achieve steady state plasma levels of 62 ± 2 and 171 ± 4 μU/ml. Intralipid caused again a significant reduction in total body glucose uptake during both the low (5.9 to 4.5 mg/kg min, p < 0.001) and the high (9.9-8.7 mg/kg min, p < 0.01) insulin clamp studies. This decrease in total glucose uptake was again the combined effect of an inhibition of both glucose storate (p < 0.05) and glucose oxidation (p < 0.001). In both high and low dose Intralipid infusion protocols, a strong inverse correlation was noted between the plasma free fatty acid concentration during the insulin clamp study and total body glucose uptake (r = 0.92, p < 0.001), glucose oxidation (r = 0.95, p < 0.001), and glucose storage (r = 0.90, p < 0.01). These results indicate that the inhibitory effect of free fatty acids on glucose utilization involves the biochemical pathways regulating both glucose oxidation and glycogen synthesis.
AB - The effect of long chain triglyceride infusions (Intralipid 20%, 1 ml/min) on total body glucose uptake, glucose oxidation and glucose storage was examined in 25 healthy young volunteers by employing the euglycemic insulin clamp technique in combination with indirect calorimetry. Insulin was infused at three different rates (0.5, 2 and 4 mU/kg min) to achieve steady state hyperinsulinemic plateaus of 60 ± 4, 170 ± 10 and 420 ± 15 μU/ml. Prior to Intralipid infusion, the mean basal plasma free fatty acid concentration of all subjects was 385 ± 8 μmole/l. Following 90 min Intralipid infusion, the mean plasma free fatty acid level was increased to 760 ± 20 μmole/l (p < 0.001). At each insulin dose level, hyperlipidemia caused a significant reduction in total glucose uptake (5.9-3.5, 9.9-7.1, 11.1-8.8 mg/kg min, all p < 0.001. The decrease in total body glucose uptake was reflected by a decrease in both total glucose oxidation (2.4-1.6, 3.4-2.2, 3.7-2.8 mg/kg min, all p < 0.001) and glucose storage (3.6-1.9, 6.5-4.9, 7.4-5.9 mg/kg min, all p < 0.001). Basal glucose oxidation (1.3 ± 0.1 mg/kg min) fell by about 30% following 90 min of Intralipid infusion (0.9 ± 0.1 mg/kg min). Six additional subjects were studied with a lower infusion rate of Intralipid (0.5 ml/min). In these studies, insulin was infused at two different doses (0.5 and 2 mU/kg min) to achieve steady state plasma levels of 62 ± 2 and 171 ± 4 μU/ml. Intralipid caused again a significant reduction in total body glucose uptake during both the low (5.9 to 4.5 mg/kg min, p < 0.001) and the high (9.9-8.7 mg/kg min, p < 0.01) insulin clamp studies. This decrease in total glucose uptake was again the combined effect of an inhibition of both glucose storate (p < 0.05) and glucose oxidation (p < 0.001). In both high and low dose Intralipid infusion protocols, a strong inverse correlation was noted between the plasma free fatty acid concentration during the insulin clamp study and total body glucose uptake (r = 0.92, p < 0.001), glucose oxidation (r = 0.95, p < 0.001), and glucose storage (r = 0.90, p < 0.01). These results indicate that the inhibitory effect of free fatty acids on glucose utilization involves the biochemical pathways regulating both glucose oxidation and glycogen synthesis.
UR - http://www.scopus.com/inward/record.url?scp=0020382402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020382402&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(82)90163-9
DO - 10.1016/0026-0495(82)90163-9
M3 - Article
C2 - 6752642
AN - SCOPUS:0020382402
SN - 0026-0495
VL - 31
SP - 1128
EP - 1136
JO - Metabolism
JF - Metabolism
IS - 11
ER -